Bristol-Myers Faces Retaliation Suit After FCA Claims Axed
An Ohio federal judge on Friday dismissed False Claims Act allegations that Bristol-Myers Squibb Co. and Otsuka America Pharmaceutical Inc. defrauded the government and used kickbacks to promote off-label sales of...To view the full article, register now.
Already a subscriber? Click here to view full article